← All organizations
Highest phase reached
Phase 2
First clinical trial
Sep 27, 2024Last known activity
Sep 27, 2024
Timeline
2020s
- Jan 1, 2020
Egle Therapeutics— Founded
Drugs by trial phase (1 distinct, 1 trials)
Phase 2 (1 own, 0 via acquisition)
Recent trials (2)
- NCT06622486OfficialPhase 1/Phase 2Sep 27, 2024
- NCT06622486Lead sponsorPhase 1/Phase 2Sep 27, 2024
Details
- Founded
- Paris, FR Jan 1, 2020
- Last known activity
- Sep 27, 2024